Login
$NPCE
$13.02 +$0.03 (0.23%) Close

$NPCE 4/A SEC Filings

Filed On Filing
29 Jun 2021 Form 4/A: Kuhn Rebecca, Chief Financial Officer

Received 8,310 shares as a grant or award · Granted 16,620 Stock Option (Right to Buy)

29 Jun 2021 Form 4/A: Favet Michael, Director

Received 27,000 shares as a grant or award · Granted 54,000 Stock Option (Right to Buy)

29 Jun 2021 Form 4/A: Morrell Martha, Chief Medical officer

Received 8,310 shares as a grant or award · Granted 16,620 Stock Option (Right to Buy)

29 Jun 2021 Form 4/A: Ridley Irina, General Counsel and Secretary

Received 5,770 shares as a grant or award · Granted 11,540 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support